An exudate is a protein-rich fluid that leaks out of blood vessels into a body cavity or tissue because of inflammation, infection, or cancer. In asbestos-related disease, exudates most often collect in the pleural space (the lining around the lungs) and are sampled by a procedure called thoracentesis. Doctors classify pleural fluid as exudate or transudate using lab criteria. This distinction helps narrow down the cause.
Origin
From the Latin exsudare, meaning "to sweat out" or "to ooze." The medical use to describe inflammatory fluid dates to 19th-century pathology, and the formal lab criteria used today (Light's criteria) were published by Richard Light in 1972.
Significance in Asbestos Context
If you develop a pleural effusion, your doctor will likely drain a sample and test whether it is an exudate or a transudate. An exudative effusion in someone with an asbestos history raises concern for mesothelioma, lung cancer, or a benign asbestos pleural effusion, and almost always triggers further workup, imaging, cytology, and sometimes a pleural biopsy or thoracoscopy. The lab report on your pleural fluid (protein level, LDH, cell counts, cytology) becomes important medical evidence both for your diagnosis and, later, for documenting how your disease was identified.
Example Sentence
The thoracentesis report described the fluid as an exudate with elevated LDH, which prompted her oncologist to order a pleural biopsy that ultimately confirmed mesothelioma.
Related Terms
Pleural effusion, transudate, thoracentesis, Light's criteria, mesothelioma, benign asbestos pleural effusion
Notes
- Ask for a copy of your pleural fluid analysis. It should list protein, LDH, glucose, cell counts, and cytology results, all of which matter for diagnosis and for any future claim.
- If cytology of the exudate is negative but suspicion of mesothelioma remains, ask whether a thoracoscopic pleural biopsy is appropriate; fluid cytology alone misses many mesotheliomas.
- A bloody (hemorrhagic) exudate in someone with asbestos exposure is particularly concerning for malignancy and warrants prompt specialist referral.
- Preserve all pathology and fluid analysis reports; these documents establish the timeline and basis of your diagnosis.
In the research library
35 studies in our medical research library mention Exudate in the title or abstract. Among the most cited:
- Utility of CEA and CA 15-3 measurements in non-purulent pleural exudates in the diagnosis of malignancy: A single-center experienceJ.M. Porcel, C. Civit, A. Esquerda, et al, 2017 · Archivos de Bronconeumología · cited 28 times
- Incidence of Discordant Pleural Fluid Exudates and Diagnostic Patterns: A Retrospective Cohort StudyD.N. Addala, R. Mercer, A. Sundaralingam, et al, 2025 · Chest · cited 1 times
- Medical thoracoscopy, results and complications in 146 patients: a retrospective studyM. Hansen, P. Faurschou, P. Clementsen, 1998 · Respiratory Medicine · cited 86 times
- Asbestos: when the dust settles an imaging review of asbestos-related diseaseH.D. Roach, G.J. Davies, R. Attanoos, et al, 2002 · Radiographics · cited 80 times
- Pearls and myths in pleural fluid analysisJ.M. Porcel, 2011 · Respirology · cited 78 times
The journals that publish most on it: Chest (3), Environmental Health Perspectives (2), The American Journal of Pathology (2).
Category: Biological & Molecular Mechanisms · All Lexicon terms A–Z
This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.